Skip to content

13F-HR filed by Krensavage Asset Management, LLC

Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-17, with 11 holding rows worth $367,575,000.

Accession
0001609251-20-000005
Filed
2020-08-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 11 entries on the cover page, a total value of $367,575,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $367,575,000 with VALUE read as thousands by filing date, 13F file number 028-16807. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock472,548$57,178,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM493,170$55,353,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock79,691$49,699,000thousands by filing date
BIOGEN INC COM09062X103Stock151,420$40,512,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM763,103$38,315,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS521,507$34,675,000thousands by filing date
MCKESSON CORP COM58155Q103Stock216,142$33,161,000thousands by filing date
ALKERMES PLCG01767105SHS1$30,362,000thousands by filing date
RTI BIOLOGICS INC74975N105COM5,851,572$18,608,000thousands by filing date
INVACARE CORP461203101COMMON STOCK876,421$5,583,000thousands by filing date
ANAPTYSBIO INC032724106COM184,846$4,129,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001609251-20-000005this filing2020-08-17acceptance time not in the bulk data set
13F-HR/A 0001609251-20-000006 base2020-08-20acceptance time not in the bulk data set